Nordea Investment Management AB Has $83.34 Million Stock Position in Genpact Limited (NYSE:G)

Nordea Investment Management AB trimmed its stake in Genpact Limited (NYSE:G - Free Report) by 2.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,417,117 shares of the business services provider's stock after selling 67,664 shares during the period. Nordea Investment Management AB owned 1.33% of Genpact worth $83,342,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Fred Alger Management LLC raised its stake in shares of Genpact by 136.7% in the fourth quarter. Fred Alger Management LLC now owns 878 shares of the business services provider's stock valued at $41,000 after purchasing an additional 507 shares in the last quarter. Janiczek Wealth Management LLC bought a new stake in Genpact in the third quarter valued at $48,000. Covestor Ltd grew its position in Genpact by 140.2% in the third quarter. Covestor Ltd now owns 1,549 shares of the business services provider's stock valued at $56,000 after acquiring an additional 904 shares during the period. Buck Wealth Strategies LLC grew its position in Genpact by 438.3% in the third quarter. Buck Wealth Strategies LLC now owns 1,825 shares of the business services provider's stock valued at $66,000 after acquiring an additional 1,486 shares during the period. Finally, State of Wyoming bought a new stake in Genpact in the fourth quarter valued at $66,000. 96.33% of the stock is owned by institutional investors.

Insider Buying and Selling at Genpact

In other news, SVP Heather White sold 11,450 shares of the company's stock in a transaction dated Monday, January 22nd. The stock was sold at an average price of $36.00, for a total value of $412,200.00. Following the completion of the transaction, the senior vice president now directly owns 21,175 shares in the company, valued at approximately $762,300. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 2.62% of the company's stock.


Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on G shares. Citigroup upped their price target on Genpact from $35.00 to $36.00 and gave the company a "neutral" rating in a research note on Wednesday, January 17th. Mizuho began coverage on Genpact in a research report on Tuesday, January 30th. They issued a "neutral" rating and a $40.00 price objective for the company. Needham & Company LLC reaffirmed a "buy" rating and issued a $40.00 price objective on shares of Genpact in a report on Friday, February 9th. Robert W. Baird restated a "neutral" rating and set a $38.00 price objective on shares of Genpact in a research report on Friday, December 15th. Finally, JPMorgan Chase & Co. upped their price target on Genpact from $42.00 to $43.00 and gave the company an "underweight" rating in a research report on Friday, February 9th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, one has given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $40.11.

Get Our Latest Research Report on Genpact

Genpact Trading Up 1.4 %

G stock traded up $0.47 during midday trading on Tuesday, reaching $33.73. 1,740,392 shares of the company's stock traded hands, compared to its average volume of 1,480,196. The business has a 50-day moving average price of $35.12 and a two-hundred day moving average price of $35.03. The company has a market capitalization of $6.10 billion, a P/E ratio of 9.83, a PEG ratio of 1.55 and a beta of 1.08. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.44 and a quick ratio of 1.44. Genpact Limited has a fifty-two week low of $29.41 and a fifty-two week high of $46.25.

Genpact (NYSE:G - Get Free Report) last released its quarterly earnings results on Thursday, February 8th. The business services provider reported $0.68 EPS for the quarter, beating analysts' consensus estimates of $0.65 by $0.03. The company had revenue of $1.15 billion for the quarter, compared to analyst estimates of $1.12 billion. Genpact had a net margin of 14.10% and a return on equity of 23.19%. Equities research analysts forecast that Genpact Limited will post 2.7 EPS for the current fiscal year.

Genpact Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 26th. Investors of record on Monday, March 11th will be paid a $0.153 dividend. The ex-dividend date of this dividend is Friday, March 8th. This is a positive change from Genpact's previous quarterly dividend of $0.14. This represents a $0.61 annualized dividend and a yield of 1.81%. Genpact's dividend payout ratio (DPR) is 17.78%.

Genpact Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology (IT) services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The company offers CFO advisory services; and environmental, social, and governance (ESG) services, such as data management, carbon accounting, human rights assessment, sustainability diligence, and ESG reporting.

Recommended Stories

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should you invest $1,000 in Genpact right now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Featured Articles and Offers

7 Must-Buy Stocks Under $20

7 Must-Buy Stocks Under $20

In this video, we highlight seven stocks under $20 that are worth a closer look.

Search Headlines: